This chapter describes the story of the clinical process starting from the entrance of the virus to the human body to the death, if happens. Humans are the only known host of Crimean-Congo hemorrhagic fever virus (CCHFV) in which disease is manifested [18]. In general, the people living in endemic areas are at risk. But some of the people have higher risk, which were described in Section V. Among the people, who are at risk, some can get the infection, and then some get the disease (Box 16-1). In a Russian study, the probability of getting the disease for subjects who had been infected was found to be 0.215; in other words, the estimated ratio of apparent to inapparent infections suggests that one of every five persons infected develops Crimean-Congo hemorrhagic fever (CCHF) [15]. This rate was reported to be much higher than other diseases such as western equine encephalitis, St. Louis encephalitis, and tick-borne encephalitis [15]. In another study from Turkey, these rates were found to be similar [14]. In that study, the infection rate was 15/55 (27%) in the endemic region, and the attack rate was 11/55 (20%). The infection rate was significantly higher 8/19 (42%) among the individuals, who had the history of tick bite [14]. The gender and the age distribution among the cases are closely related to the exposure risk to the ticks in endemic regions. Accordingly, the rate of the diseased female is 25% in Iran [1], whereas 50% in Turkey [11].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alavi-Naini R, Moghtaderi A, Koohpayeh HR, Sharifi-Mood B, Naderi M, Metanat M, Izadi M (2006) Crimean-Congo hemorrhagic fever in Southeast of Iran. J Infect 52:378–382.
Bakhtiari K, Meijers JC, de Jonge E, Levi M (2004) Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 32:2416–2421.
Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H (2005) Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol 54:385–389.
Buehler JW (1998) Surveillance. In: Rothman KJ, Greenland S (eds) Modern Epidemiology. Lippincott-Raven, Philadelphia, PA, pp 435–457.
Burt FJ, Swanepoel R, Shieh WJ, Smith JF, Leman PA, Greer PW, Coffield LM, Rollin PE, Ksiazek TG, Peters CJ, Zaki SR (1997) Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med 121:839–846.
CDC (1990) Case definitions for public health surveillance. Morb Mortal Wkly Rep 39:1–40.
Celikbas A, Ergonul O, Dokuzoguz B, Eren S, Baykam N, Polat-Duzgun A (2005) Crimean-Congo hemorrhagic fever infection simulating acute appendicitis. J Infect 50:363–365.
Celikbas A, Ergonul O, Yildirim U, Zenciroglu A, Erdogan D, Ziraman I, Yilmaz N, Saracoglu F, Demirel N, Cakmak O, Dokuzoguz B (2006) Intrauterine infection of Crimean-–Congo haemorrhagic fever: the courses of two episodes. In: 15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 12;4, Nice, France, p 1665.
Egerman RS, Sibai BM (1999) HELLP syndrome. Clin Obstet Gynecol 42:381–389.
Ergonul O, Celikbas A, Dokuzoguz B, Eren S, Baykam N, Esener H (2004) Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis 39:284–287.
Ergonul O (2006) Crimean-Congo haemorrhagic fever. Lancet Infect Dis 6:203–214.
Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B (2006) Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect 12:551–554.
Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B (2006) Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis 193:941–944.
Ergonul O, Zeller H, Menekse S, Celikbas A, Eren S, Baykam N, Dokuzoguz B (2006) The attack and the infection rate of Crimean-Congo haemorrhagic fever virus infection in an endemic region. In: 15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1–4 April 2006, Nice, France, p 1666.
Goldfarb LG, Chumakov MP, Myskin AA, Kondratenko VF, Reznikova OY (1980) An epidemiological model of Crimean hemorrhagic fever. Am J Trop Med Hyg 29:260–264.
Gozalan A, Akin L, Rolain JM, Tapar FS, Oncul O, Yoshikura H, Zeller H, Raoult D, Esen B (2004) Epidemiological evaluation of a possible outbreak in and nearby Tokat province. Mikrobiyol Bul 38:33–44.
Güngör O, Ero˘glu KO, Güven A, Kalayci AG, Duru F (2006) Crimean-Congo Hemorrhagic fever among children [Turkish]. National Pediatrics Conference, Antalya, Turkey, p 281.
Hoogstraal H (1979) The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol 15:307–417.
Karti SS, Odabasi Z, Korten V, Yilmaz M, Sonmez M, Caylan R, Akdogan E, Eren N, Koksal I, Ovali E, Erickson BR, Vincent MJ, Nichol ST, Comer JA, Rollin PE, Ksiazek TG (2004) Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 10:1379–1384.
Martini GA (1969) Marburg agent disease: in man. Trans R Soc Trop Med Hyg 63:295–302.
McCormick JB, King IJ, Webb PA, Johnson KM, O'Sullivan R, Smith ES, Trippel S, Tong TC (1987) A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 155:445–455.
Ozkurt Z, Kiki I, Erol S, Erdem F, Yilmaz N, Parlak M, Gundogdu M, Tasyaran MA (2006) Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect 52:207–215.
Peters CJ, Zaki SR (2002) Role of the endothelium in viral hemorrhagic fevers. Crit Care Med 30:S268–S273.
Rothman KJ (2002) Epidemiology: An introduction. Oxford University Press, New York.
Saijo M, Tang Q, Shimayi B, Han L, Zhang Y, Asiguma M, Tianshu D, Maeda A, Kurane I, Morikawa S (2004) Possible horizontal transmission of Crimean-Congo hemorrhagic fever virus from a mother to her child. Jpn J Infect Dis 57:55–57.
Schwarz TF, Nsanze H, Ameen AM (1997) Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates. Infection 25:364–367.
Stone JH (1998) HELLP syndrome: hemolysis, elevated liver enzymes, and low platelets. JAMA 280:559–562.
Swanepoel R, Shepherd AJ, Leman PA, Shepherd SP, McGillivray GM, Erasmus MJ, Searle LA, Gill DE (1987) Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa. Am J Trop Med Hyg 36:120–132.
Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S (1989) The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 11 (Suppl 4):S794–S800.
Tanir G, Ergonul O, Tuygun N, Golabi P, Korten V (2007) Crimean-Congo haemorrhagic fever infection among children. In: 17th European Congress of Clinical Microbiology and Infectious Diseases, Munich, Germany.
van Eeden PJ, van Eeden SF, Joubert JR, King JB, van de Wal BW, Michell WL (1985) A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part II. Management of patients. S Afr Med J 68:718–721.
Wallach J (2000) Interpretation of Diagnostic Tests, 7th edn. Lippincott Williams & Wilkins, Philadelphia, PA.
Watts DM, Ksiasek TG, Linthicum KJ, Hoogstraal H (1988) Crimean-Congo hemorrhagic fever. In: Monath TP (ed.) The Arboviruses: Epidemiology and Ecology. CRC Press, Boca Raton, FL.
Watts DM, Ussery MA, Nash D, Peters CJ (1989) Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. Am J Trop Med Hyg 41:581–585.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
Ergonul, O. (2007). Clinical and Pathologic Features of Crimean-Congo Hemorrhagic Fever. In: Ergonul, O., Whitehouse, C.A. (eds) Crimean-Congo Hemorrhagic Fever. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6106-6_16
Download citation
DOI: https://doi.org/10.1007/978-1-4020-6106-6_16
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-6105-9
Online ISBN: 978-1-4020-6106-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)